| Nome |
# |
|
New patents on topical anesthetics., file e3835311-cc5a-15e8-e053-a505fe0a3de9
|
409
|
|
Use of biological drugs in patients with psoriasis and psoriatic arthritis in italy: Results from the PSONG survey, file e383531a-3962-15e8-e053-a505fe0a3de9
|
383
|
|
MiRNAs as potential prognostic biomarkers for metastasis in thin and thick primary cutaneous melanomas, file e3835322-e799-15e8-e053-a505fe0a3de9
|
138
|
|
Metastases risk in thin cutaneous melanoma: Prognostic value of clinical-pathologic characteristics and mutation profile, file e383531d-36c4-15e8-e053-a505fe0a3de9
|
107
|
|
Psa-disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients. An italian derma-rheuma multicentre study, file e3835326-a470-15e8-e053-a505fe0a3de9
|
93
|
|
PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report, file e3835323-281b-15e8-e053-a505fe0a3de9
|
75
|
|
Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis c, file e3835314-70c4-15e8-e053-a505fe0a3de9
|
74
|
|
Paraneoplastic pemphigus. A trait d’union between dermatology and oncology, file e3835325-eeeb-15e8-e053-a505fe0a3de9
|
71
|
|
Risankizumab for the treatment of moderate-to-severe psoriasis. A multicenter, retrospective, 1 year real-life study, file f784a5fb-e6e2-484f-a58c-e0c882f7df4f
|
68
|
|
Clinicopathological predictive factors of melanoma lung metastases, file e3835325-9741-15e8-e053-a505fe0a3de9
|
62
|
|
Paradoxical psoriasis induced by Anti-TNFα treatment: Evaluation of disease-specific clinical and genetic markers, file e3835328-3b56-15e8-e053-a505fe0a3de9
|
59
|
|
null, file e744434a-6f63-46ee-858c-077cbdb45778
|
36
|
|
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis. a real-life multicenter study—IL PSO (Italian landscape psoriasis), file 365f167d-114c-4dab-a25f-3f28c68c4419
|
27
|
|
A possible link between gut microbiome composition and cardiovascular comorbidities in psoriatic patients, file 24f42b96-7322-4a3a-a546-1236ad99235e
|
20
|
|
Primary cutaneous alk positive anaplastic large cell lymphoma in a melanoma patient, file e3835325-9745-15e8-e053-a505fe0a3de9
|
19
|
|
Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent. Case report and review of literature, file e313c9ac-05c2-48bf-a57f-9e33d0b32997
|
18
|
|
Thin melanoma and late recurrences: it is never too thin and never too late, file e3835312-d605-15e8-e053-a505fe0a3de9
|
17
|
|
Peripheral blood regulatory T cell measurements correlate with serum vitamin D level in patients with psoriasis, file e3835325-bc30-15e8-e053-a505fe0a3de9
|
17
|
|
Latent tubercolosis infection in patients with cronic plaque psoriasis: evidence from the Italian Psocare Registry, file e383531a-7a33-15e8-e053-a505fe0a3de9
|
13
|
|
Agminated blue nevus: two case reports and a mini-review of the literature, file e3835314-ec65-15e8-e053-a505fe0a3de9
|
10
|
|
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy, file e3835327-f031-15e8-e053-a505fe0a3de9
|
9
|
|
Efficacy and safety of tildrakizumab in elderly patients. Real-world multicenter study (ESTER - study), file 00a391aa-7409-444d-9430-c25b34c0e870
|
6
|
|
Gut microbiome profile in psoriatic patients treated and untreated with biologic therapy, file e3835329-e63e-15e8-e053-a505fe0a3de9
|
5
|
|
Instability at sequence repeats in melanocytic tumours, file e3835311-819e-15e8-e053-a505fe0a3de9
|
4
|
|
Homocysteine plasmatic status in patients with psoriasis, file e3835311-c45a-15e8-e053-a505fe0a3de9
|
4
|
|
Superficial basal cell carcinoma successfully treated with ingenol mebutate gel 0.05%, file e3835312-dda4-15e8-e053-a505fe0a3de9
|
4
|
|
Is the prognosis and course of acral melanoma related to site-specific clinicopathological features?, file e3835315-031a-15e8-e053-a505fe0a3de9
|
4
|
|
NF1 gene analysis based on DHPLC., file e3835315-e436-15e8-e053-a505fe0a3de9
|
4
|
|
Oral features in patients with psoriasis: an observational study, file e3835323-43f2-15e8-e053-a505fe0a3de9
|
4
|
|
Case report. cetuximab use in advanced cutaneous squamous cell carcinoma resistant to chemotherapy [version 1; peer review. 1 approved with reservations], file e3835328-4302-15e8-e053-a505fe0a3de9
|
4
|
|
Morphea, an unusual side effect of anti-TNF-alpha treatment, file e3835311-974e-15e8-e053-a505fe0a3de9
|
3
|
|
A-1012G Promoter Polymorphism of Vitamin D Receptor Gene Is Associated with Psoriasis Risk and Lower Allele-Specific Expression, file e3835312-dd39-15e8-e053-a505fe0a3de9
|
3
|
|
Microsatellite instability in primary and metastatic melanoma, file e3835315-cdcd-15e8-e053-a505fe0a3de9
|
3
|
|
Serum tryptase levels in melanoma patients: first results of clinicopathological features, file e3835316-0d68-15e8-e053-a505fe0a3de9
|
3
|
|
The barrier beyond the skin, file e3835324-0869-15e8-e053-a505fe0a3de9
|
3
|
|
Increased intestinal barrier permeability in patients with moderate to severe plaque-type psoriasis, file e3835328-00ea-15e8-e053-a505fe0a3de9
|
3
|
|
Facial superficial granulomatous pyoderma, file e383532a-b78b-15e8-e053-a505fe0a3de9
|
3
|
|
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year, file 077e3e95-747b-49fa-a2ea-b989e0a06d72
|
2
|
|
Neurofibromatosi di tipo 1. Una patologia multisistemica, file e3835311-853f-15e8-e053-a505fe0a3de9
|
2
|
|
Lisch nodules of the iris in neurofibromatosis type 1, file e3835311-a29a-15e8-e053-a505fe0a3de9
|
2
|
|
Psoriasis of the dorsal surface of the tongue., file e3835311-c5f9-15e8-e053-a505fe0a3de9
|
2
|
|
CD4+ CD25+ T-regulatory cells in psoriasis. Correlation between their numbers and biologics-induced clinical improvement, file e3835311-c7f9-15e8-e053-a505fe0a3de9
|
2
|
|
Association between autoimmune disease and cutaneous melanoma with regard to melanoma prognosis, file e3835312-d902-15e8-e053-a505fe0a3de9
|
2
|
|
Metabolic syndrome prevalence in psoriasis: A cross-sectional study in the Italian population, file e3835312-dcef-15e8-e053-a505fe0a3de9
|
2
|
|
Improvement of survival in patients with melanoma and non-melanoma skin cancers compared to patients without double cutaneous malignancies, file e3835312-de88-15e8-e053-a505fe0a3de9
|
2
|
|
Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites. An update, file e3835312-e2d7-15e8-e053-a505fe0a3de9
|
2
|
|
Serum tryptase levels in melanoma patients: case-control study and review of the literature, file e3835322-cbe2-15e8-e053-a505fe0a3de9
|
2
|
|
Correlation between plasmatic levels of vitamin D and PASI score, file e3835322-cd95-15e8-e053-a505fe0a3de9
|
2
|
|
Dermatofibrosarcoma protuberans: when the age makes the difference, file e3835322-e805-15e8-e053-a505fe0a3de9
|
2
|
|
The role of estro-progestinic pills in female patients with melanoma, file e3835322-f234-15e8-e053-a505fe0a3de9
|
2
|
|
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: a case report, file e383532d-42ae-15e8-e053-a505fe0a3de9
|
2
|
|
A multidisciplinary approach for patients with moderate-to-severe psoriasis. an advisable network of management, file 190ba0fc-24a7-4d10-8fda-af54a81c8f0f
|
1
|
|
Interleukin-17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery following Secukinumab Administration, file cdffeda7-9237-4312-acea-3de2c49a8b40
|
1
|
|
NF1-gene analysis based on Denaturing high-performance liquid chromatography (DHPLC)., file e3835311-5a9e-15e8-e053-a505fe0a3de9
|
1
|
|
Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab, file e3835311-74fb-15e8-e053-a505fe0a3de9
|
1
|
|
What's new in trichothiodystrophy, file e3835311-7ce0-15e8-e053-a505fe0a3de9
|
1
|
|
Neurofibromatosis type 1 associated with systemic vasculopathy, file e3835311-9ee3-15e8-e053-a505fe0a3de9
|
1
|
|
Antibacterial activity of methyl aminolevulinate photodynamic therapy in the treatment of a cutaneous ulcer, file e3835311-c409-15e8-e053-a505fe0a3de9
|
1
|
|
“Adhesion receptors and extracellular matrix proteins in neurofibromas”, file e3835311-da4c-15e8-e053-a505fe0a3de9
|
1
|
|
Multiple squamous cell carcinomas developing in dystrophic epidermolysis bullosa., file e3835311-eca6-15e8-e053-a505fe0a3de9
|
1
|
|
Psoriasis: New insight about pathogenesis, role of barrier organ integrity, NLR/CATERPILLER family genes and microbial flora, file e3835311-f1e4-15e8-e053-a505fe0a3de9
|
1
|
|
S100 serum level: a tumour marker for metastatic melanoma, file e3835311-fba0-15e8-e053-a505fe0a3de9
|
1
|
|
“Adhesion receptors and extracellular matrix proteins in neurofibromas and neurofibrosarcomas”., file e3835312-1d74-15e8-e053-a505fe0a3de9
|
1
|
|
Videodermoscopy Scalp Psoriasis Severity Index (VSCAPSI): A useful tool for evaluation of scalp psoriasis, file e3835312-1f4a-15e8-e053-a505fe0a3de9
|
1
|
|
Importance of regulatory T cells in the pathogenesis of psoriasis: Review of the literature, file e3835312-d575-15e8-e053-a505fe0a3de9
|
1
|
|
Drug cutaneous side effect: Focus on skin ulceration, file e3835312-d5ff-15e8-e053-a505fe0a3de9
|
1
|
|
Psoriasis and bone mineral density: implications for long-term patients, file e3835314-6070-15e8-e053-a505fe0a3de9
|
1
|
|
Psoriasis, vitamin D and the importance of the cutaneous barrier's integrity: An update, file e3835314-ee90-15e8-e053-a505fe0a3de9
|
1
|
|
Melanoma and IFN alpha: Potential adjuvant therapy, file e3835315-cefc-15e8-e053-a505fe0a3de9
|
1
|
|
Clinicopathological Predictive Factors of Melanoma Lung Metastases, file e3835320-e9fe-15e8-e053-a505fe0a3de9
|
1
|
|
Cancer surveillance series: role of demographic aspects, altitude and latitude in the extracutaneous malignant melanoma in a residential study, file e3835322-e6c2-15e8-e053-a505fe0a3de9
|
1
|
|
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry, file e3835322-fbab-15e8-e053-a505fe0a3de9
|
1
|
| Totale |
1.834 |